National Bank of Canada’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,000
Closed -$6.62K 3181
2024
Q4
$6.62K Buy
10,000
+3,800
+61% +$2.64K ﹤0.01% 2403
2024
Q3
$5.26K Buy
+6,200
New +$4.74K ﹤0.01% 2196
2022
Q2
Sell
-201
Closed -$1K 3007
2022
Q1
$1K Sell
201
-316,000
-100% -$1.6M ﹤0.01% 2810
2021
Q4
$1.98M Buy
+316,201
New +$2.16M 0.01% 819

Other funds holding VXRT

National Bank of Canada's VXRT Position: Q1 2025 in Review

National Bank of Canada sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 10,000 shares — an estimated $6.62K sold.

National Bank of Canada first reported a position in VXRT in Q4 2021 and held it in 4 quarters. The position peaked at $1.98M in Q4 2021. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

  • National Bank of Canada reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
  • National Bank of Canada sold 10,000 Vaxart shares in Q1 2025, an estimated $6.62K.
  • National Bank of Canada first reported a position in Vaxart in Q4 2021 and held it in 4 quarters.
  • National Bank of Canada's Vaxart position peaked at $1.98M in Q4 2021.
  • 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on National Bank of Canada's 13F filing for Q1 2025, filed 12 May 2025.